Pregnant woman hanging white sheet in backyard; Shutterstock ID 2259906639; purchase_order: Brief #1, Loop 3: Luxury and lifestyle; job: ; client: ; other:

DSM archive

Results & investor presentations

Results, press releases & publications

Brought together here for easy access, explore all the press releases, presentations, reports, calls and webcasts DSM has published in the last decade on its financial results, Capital Markets Days and Shareholders' meetings.

2025 Integrated Annual Report


27 April, 2026

2024 Integrated Annual Report


15 April, 2025

Directly above shot of happy little Asian girl and her baby sister having fun together and playing on the bed, both of them are smiling joyfully. Siblings love. Love, bonding and togetherness
2023 Integrated Annual Report


15 May, 2024

DSM 2017 Integrated Annual Report
Annual General Meeting of Shareholders


22 June, 2023

Annual General Meeting of Shareholders
Q1 trading update


2 May, 2023

Press Release & Financial Statements in full
Webcast Co-CEOs
2022 Integrated Annual Report


2 March, 2023

iar-2022-square.jpg
iar-2022-square.jpg
2023 results


16 Feb, 2023

Press Release & Financial Statements in full
fy-2022-results-tiles.png
Webcast Co-CEOs
Q3 trading update


01 Nov, 2022

Press Release & Financial Statements in full
dsm-q3-2022-tile.jpg
Webcast Co-CEOs
H1 2022 results


02 Aug, 2022

Press Release & Financial Statements in full
tile-investors-press-release-poppy.jpg
Webcast Co-CEOs
Annual General Meeting of Shareholders

May 10th, 2022

Annual General Meeting of Shareholders
20230224 - DSM-Firmenich-Black-Logo-Primary-Digital-1920x1080.png
Q1 trading update

03 May 2022

Press Release & Financial Statements in full
Annual Report 2021

March 2nd, 2022

Annual Results

Febuary 15th, 2022

Press Release & Financial Statements in full
tile-fy2021-results.png
Webcast Co-CEOs
Q3 trading update

02 Nov

Press Release & Financial Statements in full
DSM accelerates its purpose-led, performance-driven strategic journey

14 Sep

Press Release & Financial Statements in full
20230224 - DSM-Firmenich-Black-Logo-Primary-Digital-1920x1080.png
Webcast Co-CEOs
DSM to acquire First Choice Ingredients

03 Sep

Press Release & Financial Statements in full
DSM to acquire First Choice Ingredients to accelerate growth in food and beverage
H1 2021 results

03 Aug

Press Release & Financial Statements in full
H1 2021 results
Webcast Co-CEOs
(Virtual) Annual General Meeting of Shareholders

06 May

Annual General Meeting of Shareholders
Annual Report 2020
Q1 trading update

05 May

Press Release & Financial Statements in full
Annual Report 2020

02 Mar

Annual Report 2020
Annual Report 2020
Annual Results 2020

16 Feb

Press Release & Financial Statements in full
DSM reports 2020 results
Conference Calls
(Virtual) Investor Event

04 Nov

Keynote Investor Event 2020
Nutrition: What got us here? Investor Event 2020
DSM in Food & Beverage Investor Event 2020
Delivering on our innovation ambitions Investor Event 2020
1st 9 months results

03 Nov

Press Release & Financial Statements in full
DSM reports results first nine months 2020
Conference Calls
H1 results

04 Aug

Press Release & Financial Statements in full
DSM reports H1 2020 results
Conference Calls
DSM to acquire the Erber Group

12 June

DSM to add world-leading animal nutrition and health specialty businesses with acquisition of Erber Group
Presentation to Investors: Acquisition of the Erber Group
(Virtual) Annual General Meeting of Shareholders

08 May

Annual General Meeting of Shareholders
Annual Report 2019
Q1 results

07 May

Press Release & Financial Statements in full
DSM reports Q1 2020 results
Conference Calls
Annual Report 2019

27 February

Annual Report 2019
Annual Report 2019 PDF version
DSM to acquire Glycom A/S Denmark

21 February

DSM to acquire Glycom A/S to accelerate growth in Early Life Nutrition
Presentation to Investors: DSM to acquire Glycom A/S Denmark to accelerate growth in Early Life Nutrition
Annual Results 2019

13 February

Press Release & Financial Statements in full
Presentation to Investors: Q4 & Full Year 2019 Results
Conference Calls
1st 9 months results

05 November

Press Release & Financial Statements in full
Conference Calls
H1 results

01 August

Press Release & Financial Statements in full
DSM reports H1 2019 Results
Conference Calls
Annual General Meeting of Shareholders

08 May

Annual General Meeting of Shareholders
DSM 2018 Integrated Annual Report
Q1 results

07 May

Press Release & Financial Statements in full
Q1 2019 Results
Conference Calls
Annual Report 2018

08 March

DSM 2018 Integrated Annual Report
DSM 2018 Integrated Annual Report PDF
Annual Results 2018

14 February

Annual Results 2018
Press Release & Financial Statements in full
Presentation to Investors: Full Year 2018
Conference Calls

DSM Annual Shareholder Meetings

You can access the last 10 years of DSM's Annual Shareholder Meetings recordings and information here.

tile-media-generic.jpg

DSM news archive

DSM is obliged by article 17 of the European Market Abuse Regulation to disclose price-sensitive inside information to the Dutch Authority for the Financial Markets (AFM) and to publish this information via a press release. Full details of the AFM's rules on the disclosure of inside information and relevant definitions can be found on their website. The AFM also maintains an independent public register of these press releases.

You can access all the press releases, news and company announcements published in the last 10 years.

 

Danube AG - Financial statements 2022

We have audited the financial statements of Danube AG (the Company), which comprise the balance sheet as at 31 December 2022, and the income statement for the period from 18 May 2022 till 31 December 2022, and notes to the financial statements

DSM B.V. (former Koninklijke DSM) share information

Ordinary shares Koninklijke DSM N.V.

The last trading date of the DSM Ordinary Shares was 30 May 2023. The delisting of the DSM Ordinary Shares was effective on 31 May 2023. After delisting, DSM was converted from a Dutch public limited liability company (naamloze vennootschap) into a Dutch private limited liability company (besloten vennootschap met beperkte aansprakelijkheid).

Buy-out of DSM BV (previously Royal DSM NV) shares

On May 14, 2024, the Enterprise Chamber of the Court of Appeal in Amsterdam (the Enterprise Chamber), the Netherlands rendered its judgment in the statutory buy-out proceedings initiated by DSM-Firmenich AG (the Company) to acquire any shares of DSM B.V. (DSM) not already acquired by the Company in its previously completed voluntary cash tender offers for all outstanding DSM ordinary shares (the Shares).

The Enterprise Chamber ordered all remaining DSM shareholders to transfer the unencumbered right to their Shares to the Company. It determined that €116 is the fair price per Share, subject to an increase by statutory interest calculated from May 3, 2023 until the date of transfer or consignment of the Shares, and a decrease by any distributions that become payable on the Shares in the aforementioned period. The Company was ordered to pay this fair price plus statutory interest and minus distributions in exchange for the transfer of the unencumbered right to the Shares, which resulted in an amount of €100.38 per Share.

To execute this judgment, on July 5, 2024, the Company paid this amount of €100.38 per Share into consignment with the Dutch Consignment Office (a body of the Dutch Ministry of Finance) for all Shares not offered to the Company within the voluntary transfer period that ended on 2 July 2024. With this payment, the unencumbered title to such Shares have transferred to the Company by operation of law. The former holders of these DSM shares can claim the amount of 100.38 per Share from the Consignment Office.

Former shareholders can ask their brokers to arrange this payment through Euroclear Nederland, who typically will request payment from the Consignment Office on behalf of a former shareholder.

The consignment fund procedure of the Consignment Office can be found on: https://www.rijksoverheid.nl/onderwerpen/consignatiekas/claim-indienen

Contact address:
Ministerie van Financiën, Consignatiekas, Postbus 20201, 2500 EE  Den Haag. Phone: +31 (0)88 442 8000.

Bearer shares Koninklijke DSM N.V.

In 2006, all (physical) bearer shares in DSM's issued share capital were converted into (book entry) registered shares. To exercise rights in the shares, holders of former bearer shares are required to hand in their certificates to DSM-Firmenich AG. In 2019, an amendment was made to Article 2:82 of the Dutch Civil Code stating that DSM shareholders who have not handed in their bearer share certificates will lose any entitlement to exchange their certificates for a replacement share as of January 2026.

For more information on how to hand in your bearer shares please contact ABN AMRO Bank N.V. at:

ABN AMRO Corporate Broking & Issuer Services

Email: contact.dsm-firmenich@nl.abnamro.com

Telephone number: +31 20 628 6070

Explore more